🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

BD

Biodesix IncNASDAQ BDSX Stock Report

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is BDSX undervalued compared to its fair value?

The fair value of BDSX stock is hidden USD. Relative to the market price of 1.69 USD Biodesix Inc is hidden.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 245 full-time employees. The company went IPO on 2020-10-28...[More about valuation]

Biodesix Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.19 $B

Price:

1.69 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.14

FINANCIALS

Biodesix financial for reporting period

Income Statement

0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.014 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.015 B 100%
0.012 B 79%
-0.011 B -74%
-0.014 B -92%

Balance Sheet

0.087 B
-0.0055 B

0.036 B

Financial Position Analysis

Assets

0.087 B
Current Assets
0.028 B
Total non-current assets
0.059 B

Total current liabilities
0.031 B
Total non-current liabilities
0.061 B

Cash Flow Statement

-0.016 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Biodesix fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-91 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-54 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is BDSX attractive for investment based on fundamental analysis?

BDSX stock rating is hidden. Biodesix is a hidden by Eyestock methodology.

Get BDSX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-86

Gross Margin:

76

CFO / Debt ratio:

hidden

Current ratio:

0.976

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BDSX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BDSX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Biodesix Inc competitors

UN

UNH

UnitedHealth Group Inc

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. The company is headquartered in Hopkins, Minnesota and currently...

Discover

EL

ELV

Elevance Health Inc

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, I...

Discover

CI

CI

Cigna Group

The Cigna Group is engaged in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 71,300 full-time employees. Th...

Discover

Biodesix Inc dividends

BDSX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BDSX stock

About the company Biodesix Inc

Market cap $B

0.19

Dividend yield

Shares outstanding

77.9749 B

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 245 full-time employees. The company went IPO on 2020-10-28. Biodesix is focused on using technologies with its artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs in lung disease. Biodesix is providing diagnostic testing services associated with blood-based lung tests; coronavirus disease tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Its blood-based lung cancer tests include Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. Biodesix also offers SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralizing Antibody testing.

BDSX profile

  • Ticker

    BDSX

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    28 October 2020

  • Sector

    Healthсare

  • Industry

    Health Care Providers & Services

  • Employees

    245

  • City

    Boulder

  • Address

    Suite 100, 2970 Wilderness Place

  • Cusip

    09075X108